Why is Kilitch Drugs falling/rising?

As of 23-Sep, Kilitch Drugs (India) Ltd is experiencing a slight decline in its stock price, currently at 352.40, reflecting a decrease of 0.05 (-0.01%). The stock has been on a downward trend, having fallen for the last four consecutive days, resulting in a total decline of 3.15% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Despite a healthy long-term growth in net sales and operating profit, the company has faced challenges such as low management efficiency, evidenced by a low return on equity (ROE) of 7.27%, and disappointing quarterly results, which may contribute to investor concerns.
In the broader market context, Kilitch Drugs has underperformed compared to the benchmark Sensex over the past week, with a return of -2.92% against the Sensex's -0.34%. However, it has outperformed its sector today by 0.34%. The stock's liquidity appears adequate, with a delivery volume increase of 20.95% compared to the 5-day average, suggesting some investor interest despite the recent price decline. The lack of domestic mutual fund investment may indicate a lack of confidence in the stock's current valuation, which could further pressure its price movement.